MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock from...
$347,915K
Proceeds from the sale of
future royalties, net...
$244,215K
Proceeds from issuance of
common stock pursuant...
$21,134K
Proceeds from issuance of
common stock related to...
$8,036K
Payments of deferred
offering costs
-$220K
Exercise of warrants
$4K
Maturities of marketable
securities
$1,922,514K
Sales of marketable
securities
$6,384K
Net cash provided by
financing activities
$621,524K
Net cash provided by
(used in) investing...
$118,058K
Canceled cashflow
$1,810,840K
Net increase
(decrease) in cash, cash...
-$158,159K
Canceled cashflow
$739,582K
Stock-based compensation
expense
$118,389K
Accrued expenses and
other current...
$112,267K
Non-cash interest
expense on liabilities...
$24,231K
Change in fair value of
warrant liability and...
$15,358K
Accounts payable
$9,535K
Amortization of operating
lease right-of-use...
$7,908K
Depreciation and
amortization
$7,780K
Amortization of intangible
assets
$870K
Other noncurrent
liabilities
$537K
Loss on disposal of
fixed assets
-$32K
Purchases of marketable
securities
$1,794,850K
Purchases of property and
equipment
$15,990K
Net cash used in
operating activities
-$897,741K
Canceled cashflow
$296,907K
Net loss
-$1,131,301K
Net amortization of
premium or discount on...
$27,831K
Other noncurrent
assets
$12,872K
Long-term deposits
$12,020K
Prepaid expenses and
other current assets
$9,667K
Operating lease liability
-$957K
Back
Back
Cash Flow
source: myfinsight.com
Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. (RVMD)